Exercise of over-allotment option in relation to Sanitec Corporation Ordinary Shares

Not for publication or distribution directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan or Republic of South Africa or in any other jurisdiction in which offers or sales would be prohibited by applicable law.

This announcement is not an offer to sell or a solicitation to buy securities in any jurisdiction, including the United States, Australia, Canada, Japan or Republic of South Africa. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

HELSINKI--()--Regulatory News:

Further to the announcement by Sanitec Corporation ("Sanitec") (STO:SNTC) on 10 December 2013, Sanitec today confirms that, in connection with its initial public offering, UBS Limited and Nordea Bank AB (publ), acting as stabilisation managers, have exercised the Over-allotment Option in full in respect of 7,826,086 ordinary shares in Sanitec.

Following the exercise of the Over-allotment Option, Sofia IV S.à r.l. holds 40,000,000 ordinary shares of Sanitec, representing 40 percent of Sanitec's issued ordinary share capital.

About Sanitec

Sanitec is the market leader in bathroom ceramics and a leading supplier of bathroom fixtures in the Company’s core markets with a unique portfolio of locally well-established brands. Sanitec has longstanding and stable relationships with customers, installers and other industrial partners, and develops sustainable and complete bathroom concepts including bathroom ceramics, furniture, pre-wall flushing solutions, taps and mixers, as well as baths and showers. Sanitec’s brands and products represent a high level of innovation and quality, as well as advanced design that is both functional and attractive.

Sanitec operates an integrated organisation with an unparalleled local presence to provide the best value to its customers when it comes to bathroom products. In 2012 net sales amounted to EUR 753 million, and currently Sanitec employs approximately 6,500 people working in 18 European based production plants and at the Company’s sales, product management and design and other support offices. Sanitec’s head office is located in Helsinki, Finland.

The shares in Sanitec Corporation are admitted on trading on NASDAQ OMX Stockholm under the symbol “SNTC”.

For more information about Sanitec and its products, please visit www.sanitec.com.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

The issue and the distribution of this announcement and other information in connection with the issue in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information was brought to you by Cision http://news.cision.com

Contacts

Sanitec
Niklas Alm
Head of Investor Relations
ir@sanitec.com
mob. 46 76 855 7836
or
Noora Koikkalainen
Head of Corporate Communications
sanitec.corporation@sanitec.com
tel. 358 10 662 5426

Sharing

Contacts

Sanitec
Niklas Alm
Head of Investor Relations
ir@sanitec.com
mob. 46 76 855 7836
or
Noora Koikkalainen
Head of Corporate Communications
sanitec.corporation@sanitec.com
tel. 358 10 662 5426